0001630575-20-000003.txt : 20201223
0001630575-20-000003.hdr.sgml : 20201223
20201222181736
ACCESSION NUMBER: 0001630575-20-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201223
DATE AS OF CHANGE: 20201222
EFFECTIVENESS DATE: 20201223
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vivace Therapeutics, Inc.
CENTRAL INDEX KEY: 0001630575
IRS NUMBER: 320452793
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-384119
FILM NUMBER: 201409285
BUSINESS ADDRESS:
STREET 1: 2929 CAMPUS DRIVE
STREET 2: SUITE 405
CITY: SAN MATEO
STATE: CA
ZIP: 94403
BUSINESS PHONE: 858-344-7499
MAIL ADDRESS:
STREET 1: 2929 CAMPUS DRIVE
STREET 2: SUITE 405
CITY: SAN MATEO
STATE: CA
ZIP: 94403
D
1
primary_doc.xml
X0708
D
LIVE
0001630575
Vivace Therapeutics, Inc.
2929 Campus Drive, Suite 150
San Mateo
CA
CALIFORNIA
94403
858-344-7499
DELAWARE
None
None
Corporation
true
Shuang
Qiao
2929 Campus Drive, Suite 150
San Mateo
CA
CALIFORNIA
94403
Executive Officer
Director
Edward
Hu
2929 Campus Drive, Suite 150
San Mateo
CA
CALIFORNIA
94403
Director
Leonard
Post
2929 Campus Drive, Suite 150
San Mateo
CA
CALIFORNIA
94403
Director
Tim
Shannon
2929 Campus Drive, Suite 150
San Mateo
CA
CALIFORNIA
94403
Director
Jun
Wu
2929 Campus Drive, Suite 150
San Mateo
CA
CALIFORNIA
94403
Director
Chenguang
Zhou
2929 Campus Drive, Suite 150
San Mateo
CA
CALIFORNIA
94403
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-12-11
false
true
false
0
29999993
29999993
0
false
6
0
0
0
false
Vivace Therapeutics, Inc.
/s/ Shuang Qiao
Shuang Qiao
President & CEO
2020-12-22